Results 51 to 60 of about 142,430 (206)

Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and Art Status [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: HIV infection is known to cause coagulation abnormalities by various mechanism, especially during its late course. Aim: The objective of this study is to analyse platelet count, prothrombin time and activated partial thromboplastin time
R Thulasi Raman   +5 more
doaj   +1 more source

A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X. [PDF]

open access: yes, 2008
BackgroundActivated factor X (FXa) is a vitamin K-dependent serine protease that plays a pivotal role in blood coagulation by converting prothrombin to thrombin. There are no reports of humans with complete deficiency of FX, and knockout of murine F10 is
Arruda, VR   +7 more
core   +2 more sources

Pattern of Some Haemostatic Parameters Among Patients with Tuberculosis Attending Aminu Kano Teaching Hospital

open access: yesSokoto Journal of Medical Laboratory Science, 2019
Tuberculosis (TB) is a major public health problem in Nigeria. This aim of this study was to investigate the pattern of some haemostatic parameters among patients with pulmonary tuberculosis (PTB).
Saidu H. , Muhammad A.H.* , Garba N. , Danladi S.B. and Aliyu I.A.
doaj  

Cryo-EM Structure of a Type I Anti-Prothrombin Antibody Reveals a Novel Kringle-1 Epitope and Its Functional Impact [PDF]

open access: yesStructural Dynamics
Introduction.Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPLs) that disrupt coagulation and increase thrombosis risk.
Suresh Kumar, Nicola Pozzi
doaj   +1 more source

Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?

open access: yesAllergy & Rhinology, 2013
Epistaxis is one of the most frequent emergencies in rhinology. Patients using anticoagulative medication are at increased risk for epistaxis. We evaluated the prothrombin time and the international normalized ratio (INR) in anticoagulated epistaxis ...
Michael B. Soyka M.D.   +1 more
doaj   +1 more source

Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia [PDF]

open access: yes, 2017
The most worrying complication of replacement therapy for severe hemophilia A and B is currently the occurrence of inhibitory alloantibodies against infused factor VIII and factor IX, respectively.
Franchini, Massimo   +6 more
core   +1 more source

Hubungan Hiperglikemia dengan Prothrombin Time pada Mencit (Mus musculus) yang Diinduksi Aloksan

open access: yesJurnal Kesehatan Andalas, 2015
AbstrakDiabetes mellitus mempunyai dua macam komplikasi yaitu komplikasi akut dan kronik. Komplikasi kronik DM (mikroangiopati dan makroangiopati) terjadi akibat disfungsi endotel yang disebabkan oleh berbagai proses pathogenesis yaitu hiperglikemia ...
Muhammad Ibnu Malik   +2 more
doaj  

Antithrombotic activity of Mentha longifolia in animal model

open access: yesBangladesh Journal of Pharmacology, 2018
The present research work was conducted to appraise the antithrombotic activity of Mentha longifolia using in vitro and in vivo experiments.
. Alamgeer   +3 more
doaj   +1 more source

The use of fibrinogen concentrate for the management of trauma-related bleeding. A systematic review and meta-analysis [PDF]

open access: yes, 2017
Haemorrhage following injury is associated with significant morbidity and mortality. The role of fibrinogen concentrate in trauma-induced coagulopathy has been the object of intense research in the last 10 years and has been systematically analysed in ...
Franchini, Massimo   +6 more
core   +1 more source

Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression [PDF]

open access: yes, 2004
<p><b>Background and Purpose:</b> Early clinical progression of ischemic stroke is common and is associated with increased risk of death and dependency.
Barber, M.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy